SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma.
Wenying ChenFengting HuangJing HuangYuanhua LiJuanfei PengYanyan ZhuangXianxian HuangLiting LuZhe ZhuShineng ZhangPublished in: The journal of gene medicine (2021)
The present study found that SLC45A4 prevents autophagy via AMPK/ULK1 axis in TP53 mutant PDA, which may be a promising biomarker and therapeutic target in TP53 mutant PDA.